Lenalidomide enhances myeloma-specific T-cell responses in vivo and in vitro

DOI: 10.1080/2162402X.2016.1139662

Keywords: Antigen-specific T-cells, CD45RA, CD57, immunotherapy, lenalidomide, multiple myeloma

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text